
A director at Viavi Solutions sold $2.72 million worth of shares despite the company's strong Q3 performance, which included a 43% revenue increase and EPS of $0.27, beating expectations. The stock price recently surged over 15% following these results. However, some analysts argue the stock is significantly overvalued, with a fair value estimate of $13.09 compared to the trading price above $52. This insider selling, part of $12.2 million in sales over three months, raises questions about investor sentiment despite robust business growth.